ERISA Litigation Update
The U.S. Supreme Court will hear arguments in Anderson v. Intel (No. 25-498) on October 6, 2026, regarding ERISA 401(k) plan investment challenges. The case focuses on pleading burdens for imprudence claims based on fund underperformance. Intel and several industry groups argue for a meaningful benchmark requirement, while petitioners challenge the necessity of such a benchmark. The Third Circuit upheld a summary judgment for Quest Diagnostics (No.
How this was made
The 30-second read
Why it matters
For traders, the main actionable element is the Supreme Court’s upcoming ERISA pleading-burden focus in a case tied to Intel’s plan investments; the other items are defendant-favorable dismissals/affirmances that may reduce near-term litigation overhang but are unlikely to drive large price moves without quantified financial exposure.
Market read
This is primarily a legal-standards update for ERISA litigation, with limited direct market impact but potential medium-term implications for litigation risk modeling among plan sponsors and recordkeepers.
What to watch
The excerpt does not quantify damages, settlement likelihood, or whether dismissals were with prejudice; those details would be needed to translate legal outcomes into material financial impact.
Background
The article is a law-firm ERISA litigation update summarizing notable Supreme Court, appellate, and district court developments affecting ERISA plan investment and fee/prudence claims.
Ticker impact
The Supreme Court will hear Anderson v. Intel Corporation Investment Policy Committee, focused on the pleading burden for ERISA imprudence claims tied to Intel’s 401(k) fund underperformance.
Likely limited near-term stock impact, but litigation-risk sentiment could swing if the Court narrows or expands what plaintiffs must plead.
The article is a litigation procedural update (Supreme Court argument scheduled) rather than a financial result, so direct price impact is uncertain; however, the case is explicitly about Intel’s plan committee.
The Third Circuit affirmed summary judgment in Johnson v. Quest Diagnostics, holding underperformance evidence insufficient where fiduciaries used a sound monitoring process.
Bias toward reduced downside risk for DGX related to ERISA plan investment claims, though magnitude is likely modest.
The decision is explicitly against plaintiffs and affirms summary judgment, which is directly favorable to the named defendant in the case.
A Northern District of Illinois dismissed Farrar v. Arthur J. Gallagher LLC, rejecting ERISA claims challenging Gallagher’s stable value GIC and recordkeeping/revenue-sharing allegations.
Near-term sentiment likely mildly positive due to dismissal, but not a clean end to the dispute because the court allowed a third amended complaint.
The article states dismissal of the complaint in its entirety but without prejudice, implying continued litigation risk.
Market effects
Could shift ERISA litigation pleading and benchmark standards, affecting how plan sponsors and recordkeepers assess litigation risk and monitoring documentation.
US federal appellate and district court decisions may influence nationwide ERISA litigation strategy.
Low; ERISA is US-specific and the article does not indicate cross-border regulatory spillovers.
Counterpoint
Even favorable rulings may not materially change stock risk because ERISA cases are often one of many legal exposures and settlements are possible after repleading.
Key entities
- Supreme Court caseAnderson v. Intel Corporation Investment Policy Committee
Supreme Court to hear arguments on ERISA imprudence pleading burden and meaningful benchmark requirements for plan investment underperformance claims.
- Third Circuit caseJohnson v. Quest Diagnostics Inc.
Third Circuit affirmed summary judgment for Quest, finding underperformance evidence insufficient where fiduciaries used a prudent monitoring process.
- Northern District of Illinois caseFarrar v. Arthur J. Gallagher LLC
District court dismissed ERISA claims challenging Gallagher’s stable value GIC and recordkeeping/revenue-sharing allegations, with leave to replead.
- District of Nebraska caseColston v. Ameritas Holding Company
District court dismissed ERISA fee/prudence claims, holding survey-based total fees were not meaningful benchmarks for the at-issue plan.
